On this page
How do you prepare a tropical-disease priority review voucher request?
First distinguish a request to earn a voucher from transfer or use of an existing voucher. For an award request, map the application to current disease, pathway, priority-review, ingredient and clinical-evidence criteria, including the later statutory additions described by FDA. Support each attestation with records; the 2016 guidance alone is not a complete current eligibility checklist.
Before you begin
Tropical-disease vouchers under FD&C Act section 524. Rare-pediatric vouchers and the Commissioner’s voucher pilot are different programs.
What you will prepare: A current eligibility evidence record or redemption worklist with the correct program identified.
For an award request, test every current eligibility element
Identify the tropical disease and verify that it is included under the current statutory/program list or an applicable designation order. A candidate disease mentioned in a docket is not necessarily designated. Document the qualifying application pathway, priority-review eligibility and prior-approval history of the active ingredient, including the relevant salt/ester analysis.
FDA’s current program page explains additional requirements for applications submitted after September 30, 2017: qualifying new clinical investigations other than bioavailability studies, essential to approval and conducted or sponsored by the sponsor, plus the specified attestation about prior submission of those reports to the identified foreign authorities before September 27, 2007. The final 2016 guidance predates these additions; do not stop at its older checklist.
Prepare the evidence before any attestation
Draft an eligibility table with each program criterion, the underlying record, the proposed conclusion and a regulatory/legal owner. Include clinical report identities, sponsorship documentation and a reproducible historical-submission inquiry for the attestation. Explain uncertainty instead of inserting “never submitted” when legacy records are unavailable.
The request should identify the application and product, state the voucher program and purpose, present the evidence supporting each criterion, and point to the supporting reports. A tropical-disease indication alone is insufficient to establish eligibility. Preserve the actual FDA award correspondence if a voucher is awarded.
For an existing voucher, control ownership and use separately
Redemption concerns a subsequent application. Confirm the voucher identity, current holder, documented transfer chain where applicable, intended application, applicable notice requirements and current fiscal-year fee. The voucher-use fee is distinct from other application fees. Obtain current program instructions before committing a filing date; this guide deliberately does not freeze a fee amount.
Fictional exercise: an applicant possesses a purchase agreement but not evidence that the transfer/ownership record is complete. Do not describe the voucher as ready for redemption until the responsible owner resolves that gap. If the instrument is a rare-pediatric voucher or another program’s voucher, reassess under that program rather than reusing the tropical-disease award criteria.
Keep eligibility, historical evidence and redemption separate
Prepare an award-request record before drafting the conclusion. This is a working aid for the regulatory and legal reviewers, not a ready-to-sign attestation.
| Eligibility question | Evidence to assemble | Unresolved issue to make visible |
|---|---|---|
| Which disease and designation? | Current list or applicable final designation order | A candidate docket entry mistaken for a designation |
| Which application and review basis? | Actual pathway, indication and priority-review analysis | Tropical indication treated as the entire eligibility test |
| What ingredient history? | Identity, relevant salt/ester analysis and prior-approval inquiry | Brand-name search substituted for ingredient assessment |
| Which qualifying investigations? | Report IDs, essentiality and conduct/sponsorship records | Older guidance used without the post-2017 requirements |
| What historical submissions? | Report-level history and applicable authority/country inquiry | Missing legacy records converted into a negative attestation |
For the historical-submission inquiry, identify the specific reports supporting the request. Record the repositories searched, legacy organizations involved, jurisdictions considered, records located and remaining gaps. Have the responsible reviewer connect the inquiry to the exact attestation described by the current program. “Nothing found in our current drive” is a search result with a limited scope, not proof about every historical submission.
Transaction exercise: the team receives an existing voucher through two successive transfers and starts filling out an award-eligibility table. Redirect the work to voucher identity, the documented transfer chain and the intended subsequent application. The 2016 guidance’s transfer discussion calls for a complete transfer record for redemption. Separately verify current notice and fee instructions for the planned use; a purchase agreement alone does not complete those tasks.
Do not populate this guide with a fee that silently becomes stale at the next fiscal year. Record the applicable fee source, fiscal year and date checked in the actual redemption worklist. Keep the voucher fee distinct from the application’s other fee obligations.
Use the cover-letter guide to state whether the submission seeks an award or concerns an existing voucher, and the administrative planning guide to assign evidence and submission owners.
Your preparation checklist
0/4 checkedUse this to track your review in this visit. Checks are not saved and do not establish regulatory compliance.
Frequently asked questions
Is the 2016 tropical-disease voucher guidance a complete current eligibility checklist?
No. FDA’s current program page describes additional requirements for applications submitted after September 30, 2017, including qualifying investigations and the specified historical-submission attestation. Read the older final guidance with those additions rather than assuming its publication status makes every eligibility discussion complete today.
Does a disease proposed in FDA’s public docket already qualify for the program?
Not merely because it was proposed. FDA distinguishes candidate submissions from diseases designated through the applicable process. Verify the current qualifying list or relevant final order and its actual scope. A docket title or discussion of a possible disease is insufficient evidence of designation.
Must an application redeeming a tropical-disease voucher itself treat a tropical disease?
The program distinguishes the qualifying application that earns the voucher from the subsequent application using it. FDA explains that an awarded voucher can obtain priority review designation for a later application that would not otherwise qualify. Verify the intended use and current program conditions without copying award criteria into redemption.
Is a voucher purchase agreement enough to establish readiness for redemption?
No. Reconcile the actual voucher and documented transfer chain, then address the intended application’s notice and fee work. FDA’s guidance calls for a complete transfer record to be available for redemption. Commercial ownership documentation does not itself demonstrate that every regulatory step is complete.
Sources and revisions
Requirements, source recommendations and editorial preparation advice have different roles. Review the scope and revision of the source you use.
FDA resource
FDA Tropical Disease Priority Review Voucher Program ↗Live program page reopened September 22, 2026; includes post-September 30, 2017 eligibility additions and current disease-order resources.
Guidance
Tropical Disease Priority Review Vouchers ↗Final October 2016; predates 2017 statutory eligibility additions. Used with current program information, not as a complete current eligibility checklist.
Technical specification · placement only
FDA eCTD v4.0 comprehensive hierarchy ↗Version 2.2, February 2025. Section 1.3.6. A heading identifies placement, not mandatory applicability.